Paper Details

  1. Home
  2. Paper Details

[Comparative study of 2 combined treatment regimens in stage-III to -IV ovarian cancer].

Author: EvdokimovaN I, GrigorovaT M

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study compared two treatment approaches for ovarian cancer: surgery followed by combination chemotherapy (including 5-fluorouracil, cyclophosphamide, and hexamethylamine) and a combination of chemotherapy (cytoxan), surgery, and additional combination chemotherapy. Results were better in the group receiving surgery first. Overall, patients with non-ascitic ovarian cancer had better outcomes with the surgery-first approach, while patients with ascitic ovarian cancer showed some improvement with both treatment regimens.
Paper Details　
Original Abstract of the Article :
The results of the treatment of 75 patients with ovarian carcinoma of epithelial origin are reported. The authors give a randomised clinical comparison of the efficacy of two schemes of complex treatment of 54 patients with ascitic ovarian carcinoma and 21 patients with non-ascitic ovarian carcinoma...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/7101824

データ提供：米国国立医学図書館（NLM）

Tackling Ovarian Cancer: The Power of Combined Therapies

Ovarian cancer is a serious concern, and finding the best treatment strategies is a priority. This study investigates two different approaches for stage III and IV ovarian cancer. Both involve surgery, but one group also receives chemotherapy before and after surgery, while the other only receives chemotherapy after surgery.

Early Intervention: A Key to Better Outcomes

The results are interesting! The study found that patients who had surgery at the initial stage of treatment had better outcomes. This highlights the importance of early intervention in ovarian cancer treatment. The researchers also found that a combined approach of surgery and chemotherapy before and after surgery might be more effective, but more research is needed to confirm this.

Early Detection and Treatment: A Desert Oasis for Ovarian Cancer Patients

This study reminds us of the importance of early detection and treatment for ovarian cancer. Early intervention can make a big difference in the outcome of the disease. As Dr. Camel, I encourage everyone to be aware of the signs and symptoms of ovarian cancer and seek medical help if they notice anything unusual. Early detection is our best weapon against this disease.

Dr.Camel's Conclusion

This research underscores the importance of early intervention in ovarian cancer treatment. The study suggests that a combination of surgery and chemotherapy may be more effective than surgery alone, but further investigation is crucial to confirm this. Early detection and prompt treatment are crucial for improving the survival rates and quality of life for those affected by ovarian cancer.

Date :
  1. Date Completed 1982-09-17
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

7101824

DOI: Digital Object Identifier

7101824

SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.